XML 105 R87.htm IDEA: XBRL DOCUMENT v3.20.2

Fair Value Measurements - Changes in fair value of Level 3 liabilities (Details) $ in Thousands	12 Months Ended
	Jun. 30, 2020 USD ($)
Business Combination Contingent Consideration Liability [Roll Forward]
Balance at June 30, 2020	$ (4,840)
Level 3
Business Combination Contingent Consideration Liability [Roll Forward]
Balance at June 30, 2019	0
Accretion for the time value of money	(275)
Fair value adjustment	2,988
Balance at June 30, 2020	(4,840)
Osprey Biotechnics, Inc. ("Osprey")
Business Combination Contingent Consideration Liability [Roll Forward]
Fair value adjustment	2,988
Osprey Biotechnics, Inc. ("Osprey") | Level 3
Business Combination Contingent Consideration Liability [Roll Forward]
Fair value adjustment	$ (7,553)

X

- Definition

The amount represents of increase (decrease) in the value of a contingent consideration liability acquisition related accretion for time value of money.

+ References

No definition available.

+ Details

Name:	pahc_AcquisitionRelatedAccretionForTimeValueOfMoney
Namespace Prefix:	pahc_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.

+ References

No definition available.

+ Details

Name:	pahc_BusinessCombinationContingentConsiderationLiabilityRollForward
Namespace Prefix:	pahc_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479

+ Details

Name:	us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Amount of liability recognized arising from contingent consideration in a business combination.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 35
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 25
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476

+ Details

Name:	us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Details

Name:	us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=pahc_OspreyBiotechnicsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: